Cytiva acquires Vanrx Pharmasystems, Canadian aseptic filling ... - 01 February 2021 16:01

AMERSHAM, United Kingdom, Feb. 1, 2021 /PRNewswire-AsiaNet/-- - Cytiva will now provide "idea to injection" solutions to customers and the market - Addition to portfolio supports global trends towards smaller manufacturing and the advent of personalized therapies - First acquisition by company ...

  DWHP Announces Expiration And Final Results Of Its Cash Tender... - 30 January 2021 11:36

PARK CITY, Utah, Jan. 30, 2021 /PRNewswire-AsiaNet/-- DW Healthcare Partners V, L.P. ("DWHP"), announced today the expiration and final results of its previously announced cash tender offer (the "Tender Offer") to purchase all of the outstanding ordinary shares (the "Tender Securities") of Parnell Ph...

  Phase 1 Drug Candidate GLR2007 Developed by Gan & Lee has been... - 30 January 2021 02:10

BEIJING and BRIDGEWATER, N.J., Jan. 30, 2021 /PRNewswire-AsiaNet/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai: 603087.SH), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for GLR2007, ...

  RedHill Biopharma Announces Positive DSMB Futility Review for ... - 29 January 2021 23:43

TEL AVIV, Israel and RALEIGH, N.C., Jan. 29, 2021, /PRNewswire-AsiaNet/ -- Following interim review of unblinded safety and efficacy data, independent DSMB unanimously recommends continuation of the global Phase 2/3 study of orally-administered opaganib for severe COVID-19 Opaganib targets a human cell component invo...

  12-Month Below-the-Knee Data with MedAlliance's SELUTION SLR[T... - 29 January 2021 04:14

NYON, Switzerland, January 28, 2021, /PRNewswire-AsiaNet/-- 12-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Trial at LINC 2021. The objective of this clinical investigation has been to evaluate safety and performance outcomes of SELUTION SLR[TM], MedAll...

  Alfasigma to expand its digital footprint - 29 January 2021 03:42

BOLOGNA, Italy, Jan. 28, 2021 /PRNewswire-AsiaNet/ -- Online doctorAsyou, a web platform entirely dedicated to physicians The website optimizes research on the most important and autoritative medical databases such as Pubmed, ICTRP and ClinicalTrials.gov. An entirely new area presents online...

  RedHill Biopharma Further Expands Opaganib Manufacturing Capac... - 29 January 2021 02:11

TEL AVIV, Israel and RALEIGH, N.C., Jan 28 2021 /PRNewswire-AsiaNet/ -- New agreement further expands manufacturing capacity for orally-administered opaganib following positive top-line data from its Phase 2 COVID-19 study, progress with the ongoing global Phase 2/3 study, and amid the urgent need to address emerging ...

  CROMSOURCE Consolidates Strategic Site Support Service - 28 January 2021 22:00

VERONA, Italy, January 28, 2021, /PRNewswire-AsiaNet/-- CROMSOURCE, an international contract research organization (CRO), announced today the expansion of its Strategic Site Support Service that can be provided to sites participating in clinical research studies managed by CROMSOURCE on behalf of comp...

  Sai Life Sciences announces plans to double headcount and expa... - 28 January 2021 18:52

MANCHESTER, England and HYDERABAD, India, Jan. 28, 2021/PRNewswire-AsiaNet/-- Sai Life Sciences, one of India's fastest growing Contract Research, Development & Manufacturing Organizations ( https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=double-headcount-capabilities-expansion-uk) (CRDMOs), today ann...

  Mallinckrodt Receives Approval in Japan of the CELLEX(R) Extra... - 28 January 2021 12:00

DUBLIN, Jan. 22, 2021 /PRNewswire-AsiaNet/ -- Mallinckrodt plc ( https://c212.net/c/link/?t=0&l=en&o=3044095-1&h=4196795004&u=http%3A%2F%2Fwww.mallinckrodt.com%2F&a=Mallinckrodt+plc ), a global biopharmaceutical company, announced today that Japan's Ministry of Health, Labour and Welfare (MHL...